# Vall d'Hebron Institute of Oncology

> cancer research institute in Spain

**Wikidata**: [Q81933223](https://www.wikidata.org/wiki/Q81933223)  
**Source**: https://4ort.xyz/entity/vall-d-hebron-institute-of-oncology

## Summary
The Vall d'Hebron Institute of Oncology (VHIO) is a cancer research institute located in Barcelona, Spain. Founded in 2002, the institute is part of the CERCA Institute and focuses its work on biomarkers, genetics, and oncology. It is headquartered at the Vall d'Hebron Hospital Universitari.

## Key Facts
- **Established**: 2002
- **Location**: Barcelona, Spain (Postal Code 08035)
- **Primary Focus**: Oncology, Cancer, Genetics, Biomarkers
- **Director/Manager**: Josep Tabernero Caturla
- **CEO**: Solange Peters (Tenure started 2020); Previous CEO: Josep Tabernero Caturla (Tenure ended 2020)
- **Parent Organization**: CERCA Institute; Catalan Association of Research Centres
- **Website**: https://www.vhio.net/ (Available in Catalan, Spanish, English)
- **Contact**: +34-932-54-34-50 | info@vhio.net
- **Address**: Passeig Vall d'Hebron, 119-129 - Edifici Mediterrània o Collserola

## FAQs
### Q: Where is the Vall d'Hebron Institute of Oncology located?
A: The institute is located in Barcelona, Spain, specifically within the facilities of the Vall d'Hebron Hospital Universitari at Passeig Vall d'Hebron, 119-129.

### Q: What are the main research areas of VHIO?
A: VHIO specializes in oncology research, with specific fields of work including cancer, genetics, and the development of biomarkers.

### Q: Who leads the Vall d'Hebron Institute of Oncology?
A: Josep Tabernero Caturla serves as the Director and Manager of the institute. Solange Peters became the CEO in 2020.

### Q: Is VHIO part of a larger network?
A: Yes, it is a member of the CERCA Institute and the Catalan Association of Research Centres.

## Why It Matters
The Vall d'Hebron Institute of Oncology (VHIO) serves as a prominent hub for specialized cancer research within the Spanish and European scientific communities. By integrating its facilities directly within the Vall d'Hebron Hospital Universitari, VHIO positions itself at the interface of clinical practice and translational research, focusing on the discovery and application of biomarkers and genetic insights to oncology.

As a member of the CERCA Institute and the Catalan Association of Research Centres, VHIO contributes significantly to the research infrastructure of Catalonia. Its establishment in 2002 marked a dedicated effort to consolidate high-level oncological research in the region, covering critical areas such as genetics and molecular biomarkers. The institute maintains a robust digital and academic presence, evidenced by its multilingual outreach and standard research identifiers (ROR, ISNI, Ringgold), facilitating global collaboration and data integration.

## Notable For
- **Specialized Research Focus**: Dedicated exclusively to oncology, with sub-focuses on genetics and biomarkers.
- **Clinical Integration**: Headquarters are located directly within the Vall d'Hebron Hospital Universitari complex.
- **CERCA Membership**: Part of the exclusive CERCA Institute network of research centers in Catalonia.
- **Multilingual Accessibility**: Offers website content and resources in Catalan, Spanish, and English.

## Body
### History and Leadership
The Vall d'Hebron Institute of Oncology (VHIO) was founded in 2002. It operates under the management of Director Josep Tabernero Caturla. In 2020, the executive leadership transitioned when Solange Peters assumed the role of CEO, succeeding Josep Tabernero Caturla, who had served in that capacity until 2020.

### Location and Facilities
VHIO is situated in Barcelona, Spain. Its physical address is Passeig Vall d'Hebron, 119-129, located in the "Edifici Mediterrània o Collserola" building, postal code 08035. The institute's geographic coordinates are approximately 41.428691° N, 2.137503° E. It is officially named after and headquartered at the Vall d'Hebron Hospital Universitari.

### Research and Scope
Classified as a research institute and research center, VHIO's primary mandate is scientific research. Its designated fields of work include:
- Oncology
- Cancer
- Genetics
- Biomarkers

### Identifiers and Digital Presence
VHIO maintains a distinct identity through various academic and governmental registries:
- **ROR ID**: 054xx3904
- **ISNI**: 0000000405638855
- **Ringgold ID**: 196659
- **KISTI ID**: K000210935
- **EU VAT Number**: ESG64384969
- **EU Transparency Register ID**: 359409042592-73
- **EU Participant Identification Code**: 995163935

The institute maintains an active online presence at `https://www.vhio.net/` with an RSS feed available at `https://www.vhio.net/en/feed/`. It also operates social media accounts on platforms such as Twitter (@VHIO) and Bluesky (@vhio.bsky.social).

## References

1. [Source](https://cerca.cat/c/vhir/)
2. Aligned ISNI and Ringgold identifiers for institutions
3. ROR release v1.1